Wuhan HongyouJie HYJTirzepatide
Ordered Tirzepatide from Wuhan HongyouJie HYJ? Mail in a sample (US only) and let us test it for free.
Test my supplyA March purity miss at 98.9% breaks an earlier run of high-purity identity passes for this tirzepatide pair. Batch identifiers are absent, so the evidence is useful but thin for batch-level consistency.
WHOIS, Wayback, and marketplace profiles undercut HYJ’s legacy-manufacturer posture, with unresolved Chinese registry and address conflicts. The report also maps Mia Su/Mia51888, UEEShop infrastructure, forum fulfilment complaints, and still-unverified payment rails.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Wuhan HongyouJie HYJ rows.
Cancel anytime
About Wuhan HongyouJie HYJ test results from Finnrick
Wuhan HongyouJie HYJ is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 7 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Wuhan HongyouJie HYJ peptides in this dataset are Retatrutide (3 tests) and Tirzepatide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 7 recent tests.
Ordered Tirzepatide from Wuhan HongyouJie HYJ? Mail in a sample (US only) and let us test it for free.
Test my supply